+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

The efficiency of different detection strategies of human African trypanosomiasis by T. b. gambiense



The efficiency of different detection strategies of human African trypanosomiasis by T. b. gambiense



Tropical Medicine and International Health 10(4): 347-356



Population screening for human African trypanosomiasis (HAT) is often based on a combination of two screening tests: lymph node palpation (LN) and card agglutination test for trypanosomiasis (CATT). This decision analysis compared the efficiency of three alternative detection strategies: screening by LN only, CATT only and their combination (LN and CATT). An HAT detection strategy was defined as the sequence of screening and confirmation. Efficacy was evaluated in terms of lives saved. The cost of screening and confirmation tests was estimated in US$. The different parameters in the decision tree were based on published literature and observations of the HAT control programme in the Democratic Republic of Congo. A sensitivity analysis was carried out on those parameters subject to uncertainty. The cost-effectiveness of a detection strategy based on CATT was US $125 per life saved, compared with US $517 for LN and US $452 for the combined. Marginal cost to add LN to CATT only was between US $1225 and US $5000 per life saved. Sensitivity analysis shows that these results are robust to variation. The CATT strategy was the most efficient. None of the strategies was able to avoid more than 60% of HAT deaths. This moderate efficacy is due to the low sensitivity of the confirmatory (diagnostic) tests. Substantial efficiency gains can be obtained by adopting a CATT only strategy and resources can be better allocated to more sensitive confirmatory tests or to increasing the coverage of populations at risk.

(PDF emailed within 0-6 h: $19.90)

Accession: 050625700

Download citation: RISBibTeXText

PMID: 15807799

DOI: 10.1111/j.1365-3156.2005.01391.x


Related references

Contemporary and emerging strategies for eliminating human African trypanosomiasis due to Trypanosoma brucei gambiense: review. Tropical Medicine and International Health 20(6): 707-718, 2015

Syndromic algorithms for detection of gambiense human African trypanosomiasis in South Sudan. Plos Neglected Tropical Diseases 7(1): E2003, 2013

The impact of passive case detection on the transmission dynamics of gambiense Human African Trypanosomiasis. Plos Neglected Tropical Diseases 12(4): E0006276, 2018

Trypanosoma brucei gambiense Spliced Leader RNA Is a More Specific Marker for Cure of Human African Trypanosomiasis Than T. b. gambiense DNA. Journal of Infectious Diseases 212(12): 1996-1998, 2016

Prevalence and under-detection of gambiense human African trypanosomiasis during mass screening sessions in Uganda and Sudan. Parasites and Vectors 5: 157, 2013

Diagnostic accuracy and feasibility of serological tests on filter paper samples for outbreak detection of T.b. gambiense human African trypanosomiasis. American Journal of Tropical Medicine and Hygiene 83(2): 374-379, 2010

The elimination of human African trypanosomiasis is in sight: Report from the third WHO stakeholders meeting on elimination of gambiense human African trypanosomiasis. Plos Neglected Tropical Diseases 12(12): E0006925, 2018

Preliminary evaluation of LATEX/T. b. gambiense and alternative versions of CATT/T. b. gambiense for the serodiagnosis of Human African Trypanosomiasis of a population at risk in Cote d'Ivoire: Considerations for mass-screening. Acta Tropica 76(2): 175-183, 18 September, 2000

Evaluation of the micro-CATT, CATT/Trypanosoma brucei gambiense, and LATEX/T b gambiense methods for serodiagnosis and surveillance of human African trypanosomiasis in West and Central Africa. Bulletin of the World Health Organization 80(11): 882-886, 2002

Human African trypanosomiasis due to T. b. gambiense: a 7-day course of DFMO could be enough!. Publication International Scientific Council for Trypanosomiasis Research and Control 1995; ( 117): 104-106, 1993

Report on a meeting of the product development team for African trypanosomiasis chemotherapy to review the comparative study of 14-day versus 7-day treatment of late stage T. b. gambiense African trypanosomiasis with eflornithine, WHO, Geneva, 14 July 1998. Report on a meeting of the product development team for African trypanosomiasis chemotherapy to review the comparative study of 14 day versus 7 day treatment of late stage T b gambiense African trypanosomiasis with eflornithine, WHO, Geneva, 14 July 1998: 8 pp., 1998

Card agglutination test for trypanosomiasis (CATT) end-dilution titer and cerebrospinal fluid cell count as predictors of human African Trypanosomiasis (Trypanosoma brucei gambiense) among serologically suspected individuals in southern Sudan. American Journal of Tropical Medicine and Hygiene 71(3): 313-317, 2004

Some new cases of congenital human African trypanosomiasis (T. gambiense). Medecine Tropicale 39(1): 57-63, 1979

The fight against the last foci of human African trypanosomiasis due to T. gambiense. Medecine Tropicale 26(4): 357-362, 1966

The heart in human african trypanosomiasis due to trypanosoma gambiense. Bulletin de la Societe de Pathologie Exotique 60(2): 142-156, 1967